Lung Disease Complicates RA Care - Takeaways - MDSpire
From the Journals

Lung Disease Complicates RA Care

Patients with chronic lung disease had numerically lower remission rates and substantially more serious adverse events in a 5-year Japanese registry study of late-onset rheumatoid arthritis.

  • By

  • Andrea Surnit

  • May 8, 2026

  • 4 min

Share

  • 1

    Study on treat-to-target strategy for rheumatoid arthritis patients over

  • 2

    Focus on 197 methotrexate-naïve patients, including 47 with chronic lung disease (CLD).

  • 3

    29.8% of CLD patients achieved remission at 5 years.

  • 4

    Increased adverse events and poorer functional status noted in CLD group.

  • 5

    Treatment adherence issues due to comorbidities in 34% of CLD patients.

  • 6

    Need for more data on managing ILD and SAEs in this patient population.

Original Source(s)

Lung Disease Complicates RA Care

  • by Andrea Surnit

  • May 8, 2026

Related Content

Serum Urate Goals Tied to Lower CV Risk

Patients with gout who reached serum urate targets had modestly higher 5-year cardiovascular event-free survival, with associations strongest among high-risk patients

Tofacitinib vs Adalimumab Findings Require Caution in RA

Meta-analysis favored tofacitinib for some rheumatoid arthritis outcomes, but high heterogeneity, dose-dependent effects, and JAK inhibitor safety concerns complicate interpretation.

Deep Remission Tied to RA Control

At 5 years, 63% of patients in the CliDR group maintained sustained remission compared with 38% in the non-CliDR group.